Blog | HemaCare

Experimental Blood Therapy May Cure Ebola

Feb 9, 2015 1:00:56 PM / by Shweta posted in blood, antibodies, convalescent plasma therapy, research, virus, whole blood

0 Comments

Convalescent plasma therapy could be an effective treatment to fight against the Ebola virus

The Ebola virus causes a serious and deadly disease transmitted by animals and humans. The current Ebola epidemic is the largest outbreak in history, affecting many countries in West Africa. The Ebola virus likely originated in African fruit bats, but apart from zoonotic transmission it can also be transmitted from one human to another via direct contact such as through broken skin or mucous membranes, bodily secretions or fluids, or by contact with surfaces and materials (e.g. bedding, clothing) contaminated with these fluids. So far, no FDA-approved vaccine or medicine is available to treat Ebola infection. Only a few primary prevention measures are available which are largely based on symptomatic treatment and by avoiding direct contact with infected people and animals.

Read More

PBMCs Used to Generate Humanized Mice to Study Asthma

Mar 17, 2014 6:24:09 AM / by Maria posted in antibodies, drug development, Independent validation, PBMCs

0 Comments

Independent publication uses peripheral blood mononuclear cells (PBMCs) supplied by HemaCare to explore the effects of IgE sequestration in a humanized mouse model of immunoglobulin production

Read More

Will T Cells Be the Future Basis of Cancer Therapy?

Mar 12, 2014 6:00:07 AM / by Maria posted in PBCs, antibodies, Bone marrow, cancer, Cancer Immunology, cell therapy, chemotherapy, cord blood, drug development, Innovation, Peripheral blood cells, peripheral blood mononuclear cells, research, stem cell therapy, stem cells, T cells, T lymphocytes, tumor

0 Comments

Recent data suggest that the average person has about a 40% chance of developing cancer at some point in his or her lifetime. [1] If those statistics are not frightening enough, let’s talk treatment: chemotherapy, radiation, surgery, chemical-based drug therapy, or a combination of the above. And don’t forget the various side effects of cancer therapy, many of which are a result of the destruction of crucial adult stem cells in the body. Because of this, stem cell transplants have been performed with fresh stem cells originating from bone marrow, peripheral blood, or cord blood to help replenish a patient’s hematopoietic system.

Read More

Revolutionizing Drug Discovery with Mass-Tag Cellular Barcoding and PBMCs

Feb 6, 2014 12:00:09 PM / by Maria posted in drug screening, PBCs, antibodies, drug development, drug discovery, Innovation, mass cytometry, mass-tag cellular barcoding, MCB, Peripheral blood cells, peripheral blood mononuclear cells, phosphorylation, research

0 Comments

Using peripheral blood mononuclear cells (PBMCs) with a new technique called mass-tag cellular barcoding (MCB) may change the drug discovery game as we know it.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts